EAE: imperfect but useful models of MS
't Hart B. A. et al.
Trends in Molecular Medicine - March 2011 - (PDF 245.41 KB) |
 |
CD161highCD8+T cells bear pathogenetic potential in Multiple Sclerosis
Annibali V. et al.
Brain - January 2011 - (PDF 1.54 MB) |
|
Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting MS receiving interferon beta-1a in the COGnitive Impairment in MS
Bastianello S. et al.
BMC Neurology - 2011 - (PDF 341.10 KB) |
|
Association of HLA class I markers with MS in the Italian and UK population: evidence of two independent protective effects
Bergamaschi L. et al.
Journal Med Jenet - September 2011 - (PDF 228.09 KB) |
|
Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination
Brambilla R. et al.
Brain - September 2011 - (PDF 3.38 MB) |
|
Methylation-dependent PAD2 upregulation in Multiple Sclerosis peripheral blood
Calabrese R. et al.
Multiple Sclerosis Journal - July 2011 - (PDF 1,007.71 KB) |
|
A role for inflammatory mediators in the modulation of the neurotrophin receptor p75NTR on human muscle precursor cells
Colombo E. et al.
Journal of Neuroimmunology - December 2011 |
|
Human Neurotrophin Receptor p75NTR defines differentiation-oriented skeletal muscle precursor cells: implications for muscle regeneration
Colombo E. et al.
Journal Neuropathology Exp. Neurology - February 2011 - (PDF 2.28 MB) |
|
The neurotrophin recepor p75NTR is induced on mature myofibres in inflammatory myopathies and promotes myotube survival to inflammatory stress
Colombo E. et al.
Neuropathol. Appl. Neurobiol. - August 2011 |
|
Experimental autoimmune encephalomyelitis (EAE) as a model for Multiple Sclerosis
Constantinescu C.S. et al.
British Journal of Pharmacology - January 2011 - (PDF 1.85 MB) |
|
Association of the CBLB gene with MS: new evidence from a replication study in an Italian population
Corrado L. et al.
Journal Med Jenet - December 2011 - (PDF 73.81 KB) |
|
Identification of the Synthetic Cannabinoid R(+)WIN55,212-2 as a novel regulator of IFn regulatory factor 3 activation and IFN Beta expression
Downer E. J. et al.
Journal of Biological Chemistry - March 2011 - (PDF 1.01 MB) |
|
Neopterin production and tryptophan degradation during 24-months therapy with Interferon Beta-1a in Multiple Sclerosis patients
Durastanti V. et al.
Journal of Translational Medicine - 2011 - (PDF 284.66 KB) |
|
2D immunomic approach for the study of IgG autoantibodies in the experimental model of MS
Farinazzo A. et al.
Journal of Neuroimmunology - 2011 - (PDF 402.47 KB) |
|
Meningeal inflammation is widespread and linked to cortical pathology in MS
Howell O. W. et al.
Brain - September 2011 - (PDF 2.00 MB) |
|
Discrepant effects of human interferon-gamma on clinical and immunological disease parameters in a novel marmoset model for MS
Jagessar S. A. et al.
Journal Neuroimmune Pharmacol. - October 2011 - (PDF 865.60 KB) |
|
Histamine regulates autoreactive T cell activation and adhesiveness in inflamed brain microcirculation
Lapilla M. et al.
Journal of Leukocyte Biology - February 2011 - (PDF 1.39 MB) |
|
Association of melanoma and natalizumab therapy in the Italian MS population: a second case report
Laroni A. et al.
Neurol Sci - February 2011 - (PDF 98.94 KB) |
|
Can we kill and extra bird with the same stone?
Laroni A. et al.
Inflamm Bowel Dis - June 2011 - (PDF 43.47 KB) |
|
IL-27 imparts immunoregulatory function to human NK cell subsets
Laroni A. et al.
PLoS ONE - October 2011 - (PDF 256.44 KB) |
|
Epstein-Barr virus nuclear antigen-I B-cell epitopes in Multiple Sclerosis twins
Mechelli R. et al.
Multiple Sclerosis Journal - April 2011 - (PDF 463.02 KB) |
|
Gender-based blood transcriptomes and interactomes in Multiple Sclerosis: involvement of SP1 dependent gene transcription
Menon R. et al.
Journal of Autoimmunity - November 2011 |
|
Shared Molecular and Functional Frameworks among five complex human disorders: a comparative study on interactomes linked to susceptibility genes
Menon R. et al.
PLoS ONE - April 2011 - (PDF 670.13 KB) |
|
Multiscale mathematical modeling to support drug development
Nordsletten D. A. et al.
IEEE Transactions on Biomed. Engineering - December 2011 - (PDF 363.79 KB) |
|
TLR2 stimulation drives human naive and effector regulatory T Cells into a Th17-like phenotype with reduced suppressive funtion
Nyirenda M. H. et al.
Journal of Neuroimmunology - September 2011 - (PDF 3.36 MB) |
|
A case of thyroiditis during natalizumab therapy for Multiple Sclerosis
Oddo S. et al.
Endocrinol Invest - May 2011 - (PDF 49.47 KB) |
|
Exacerbated experimental autoimmune encephalomyelitis in mast-cell-deficent Kit W-sh/W-sh mice
Piconese S. et al.
Laboratory Investigation - April 2011 - (PDF 665.17 KB) |
|
The matricellular protein SPARC supports follicular dendritic cell networking toward Th17 responses
Piconese S. et al.
Journal of Autoimmunity - September 2011 - (PDF 2.00 MB) |
|
Identification of two major conformational aquaporin-4 epitopes for neuromyelitis optica autoantibody binding
Pisani F. et al.
Journal Biol. Chem. - March 2011 |
|
Age-related changes of serum N-acetyl-aspartate in healthy controls
Ruggieri M. et al.
Age Ageing - May 2011 |
|
Serum levels of N-acetylaspartate in Huntington's disease: preliminary results
Ruggieri M. et al.
Mov. Disord. - October 2011 |
|
Increase of Ki-67+ natural killer cells in MS patients treated with interferon-beta and interferon-beta combined with low-dose oral steroids
Sanvito L. et al.
Journal of Neuroimmunology - May 2011 - (PDF 1.05 MB) |
|
Serum N-acetylaspartate level in amyotrophic lateral sclerosis
Simone I. L. et al.
Arch. Neurol. - October 2011 |
|
Genetic risk and a primary role for cell-mediated immune mechanisms in Multiple Sclerosis
The International MS Genetics Consortium
Nature - August 2011 - (PDF 1.13 MB) |
|
The genetic association of variants in CD6, TNFRSF1A and IRF8 to Multiple Sclerosis: a multicenter case-control study
The International MS Genetics Consortium
PLoS ONE - April 2011 - (PDF 266.76 KB) |
|
Serum and CSF N-acetylasparate levels differ in Multiple Sclerosis and neuromyelitis optica
Tortorella C. et al.
Journal Neurology Neurosurgery Psychiatry - December 2011 |
|
Mesenchymal stem cells for the treatment of MS and other neurological diseases
Uccelli A. et al.
The Lancet Neurology - July 2011 - (PDF 798.77 KB) |
|
Neuroprotective features of mesenchymal stem cells
Uccelli A. et al.
Best Practice & Research Clinical Haematology - March 2011 - (PDF 276.46 KB) |
|
OREMPdb: a semantic dictionary of computational pathway models
Umeton R. et al.
BMC Bioinformatics - 2011 - (PDF 638.81 KB) |
|
Hashimoto encephalopathy and antibodies against dimethylargininase-1: a rare cause of cognitive decline in a pediatric Down's syndrome patient
Verhelst H. et al.
Clinical Neurology and Neurosurgery - 2011 - (PDF 97.86 KB) |
|
The use of ID migraineTM questionnaire in patients with Multiple Sclerosis
Villan V. et al.
Neurol Sci - January 2011 - (PDF 163.09 KB) |
|
